For the Inventor, By the Inventor

Enter assignee name

Honolulu, HI, United States of America

Cardax Pharmaceuticals, Inc.

USPTO Granted Patents = 12

% Expired Patents = 41.7

Forward Citations = 38

Loading Chart...

Loading Chart...

14 inventors (with patents filed for the assignee):

Samuel Fournier Lockwood (12 out of 13 patents)

Henry Lee Jackson (11 out of 14 patents)

Geoff Nadolski (11 out of 12 patents)

4. Sean O'Malley (9 out of 14 patents)

5. David G Watumull (8 out of 9 patents)

6. Laura M Hix (8 out of 9 patents)

7. William Bert Geiss (2 out of 15 patents)

8. Zhiqiang Fang (2 out of 3 patents)

9. Richard Williams (2 out of 9 patents)

10. David C Burdick (2 out of 4 patents)

11. Peng Cho Tang (2 out of 118 patents)

12. Yishu Du (2 out of 2 patents)

13. Min Yang (2 out of 2 patents)

14. R Preston Mason (1 out of 4 patents)

12 patents: Sort by Forward Citations

1. 8063101 - Carotenoid analogs and derivatives for the prevention of platelet aggregation (2011-11-22),

2. 7763649 - [object Object] (2010-07-27),

3. 7723327 - Carotenoid ester analogs or derivatives for the inhibition and amelioration of liver disease (2010-05-25),

4. 7691901 - Carotenoid analogs or derivatives for the inhibition and amelioration of inflammation (2010-04-06),

5. 7592449 - Structural carotenoid analogs for the inhibition and amelioration of disease (2009-09-22),

6. 7521584 - Carotenoid analogs or derivatives for the inhibition and amelioration of disease (2009-04-21),

7. 7435861 - Methods for synthesis of carotenoids, including analogs, derivatives, and synthetic and biological intermediates (2008-10-14),

8. 7375133 - Pharmaceutical compositions including carotenoid ether analogs or derivatives for the inhibition and amelioration of disease (2008-05-20),

9. 7345091 - Carotenoid ether analogs or derivatives for the inhibition and amelioration of disease (2008-03-18),

10. 7320997 - Pharmaceutical compositions including carotenoid ester analogs or derivatives for the inhibition and amelioration of disease (2008-01-22),

11. 7317008 - Carotenoid ester analogs or derivatives for the inhibition and amelioration of ischemic reperfusion injury (2008-01-08),

12. 7247752 - Methods for the synthesis of astaxanthin (2007-07-24),

Company Overview

Cardax Pharmaceuticals, Inc. is a biotechnology company based in Honolulu, Hawaii, focused on developing innovative therapeutic solutions. The company specializes in the research and commercialization of products aimed at addressing chronic diseases through its proprietary technologies. Cardax is particularly engaged in the fields of inflammation and oxidative stress, leveraging its expertise to create potential treatments that enhance health and well-being. Its commitment to scientific advancement positions it as a notable player in the pharmaceutical landscape.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

12 Patents

#11 in Honolulu, HI

#15 in Hawaii

#25,540 in US

#48,129 in the World

Honolulu, HI, United States of America

Cardax Pharmaceuticals, Inc.

Forward Citations = 38

14 inventors:

Samuel Fournier Lockwood (12 out of 13 patents)

Henry Lee Jackson (11 out of 14 patents)

Geoff Nadolski (11 out of 12 patents)

4. Sean O'Malley (9 out of 14 patents)

5. David G Watumull (8 out of 9 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Cardax Pharmaceuticals, Inc.. Retrieved from https://idiyas.com/company/cardax-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…